Increased blood mercury levels in patients with Alzheimer’s disease.

“Alzheimer’s disease (AD) is a common neurodegenerative disorder that leads to dementia and death. In addition to several genetic parameters, various environmental factors may influence the risk of getting AD. In order to test whether blood levels of the heavy metal mercury are increased in AD, we measured blood mercury concentrations in AD patients (n = 33), and compared them to age-matched control patients with major depression (MD) (n = 45), as well as to an additional control group of patients with various non-psychiatric disorders (n = 65). Blood mercury levels were more than two-fold higher in AD patients as compared to both control groups (p = 0.0005, and p = 0.0000, respectively). In early onset AD patients (n = 13), blood mercury levels were almost three-fold higher as compared to controls (p = 0.0002, and p = 0.0000, respectively). These increases were unrelated to the patients’ dental status. Linear regression analysis of blood mercury concentrations and CSF levels of amyloid beta-peptide (A beta) revealed a significant correlation of these measures in AD patients (n = 15, r = 0.7440, p = 0.0015, Pearson type of correlation). These results demonstrate elevated blood levels of mercury in AD, and they suggest that this increase of mercury levels is associated with high CSF levels of A beta, whereas tau levels were unrelated. Possible explanations of increased blood mercury levels in AD include yet unidentified environmental sources or release from brain tissue with the advance in neuronal death.”

#Mercury #Alzheimers #MedScienceResearch

The neurotoxicity of environmental aluminum is still an issue

#Parkinsons #Alzheimers
#Neurodegenerative #Aluminum
#Vaccine #MedScienceResearch

Prolonged exposure to low levels of aluminum leads to changes associated with brain aging and neurodegeneration.

“Epidemiological studies suggest that aluminum may not be as innocuous as was previously thought and that aluminum may actively promote the onset and progression of Alzheimer’s disease.”

#Aluminum #Alzheimers
#Neurological #MedScienceResearch

Vaccination to Alzheimer Disease. Is it a Promising Tool or a Blind Way?

“Unfortunately, the promising vaccines like the AN 1792 were halted during clinical trials because of adverse effects like meningoencephalitis.”

#Vaccine #Failure #Alzheimers #Neurological #MedScienceResearch